logo
Popular weight-loss drugs show promising new power against debilitating migraines

Popular weight-loss drugs show promising new power against debilitating migraines

Fox News3 days ago
Beyond diabetes control and weight management, GLP-1s could have yet another benefit: helping with migraines.
In a small study, a GLP-1 drug shrank the number of days people spent with a migraine by almost half in a given month.
Presented at the European Academy of Neurology Congress in Helinski, Finland, on June 21, the results suggest promising future uses of the popular obesity and diabetes drugs.
Nearly 40 million Americans deal with migraines, according to the World Health Organization (WHO) — and for many, they're more than just a headache.
Migraines are the second-leading cause of disability worldwide, the above agency states, with symptoms including severe headaches, nausea and sensitivity to light often disrupting daily activities.
Previous studies have shown that GLP-1s can reduce pressure inside the skull, which is a possible cause of migraines, according to multiple health organizations.
Neurologist and study lead Simone Braca of the University of Naples Federico II in Italy, along with his colleagues, explored whether liraglutide, an earlier version of glucagon-like peptide-1 receptor agonists (GLP-1 RAs), could help migraine sufferers.
"Most patients felt better within the first two weeks and reported quality of life improved significantly."
Thirty-one adults, 26 of them women, got daily injections of liraglutide for 12 weeks. The participants, who all met the criteria for obesity, also continued to take their current migraine medications.
At the start of the experiment, participants reported headaches about 20 days out of a month. After 12 weeks of liraglutide, the average number dropped to about 11 days.
"Most patients felt better within the first two weeks and reported quality of life improved significantly," said Braca in a press release.
The relief from migraines lasted for the full three-month observation period, the researcher noted, although weight loss was "modest and statistically non-significant."
Participants' weight stayed about the same during the trial, suggesting that the headache reductions weren't tied to weight loss.
"Liraglutide is a 'middle-aged' GLP-1, with Ozempic and Mounjaro being newer," Dr. Sue Decotiis, a triple board-certified weight loss specialist in New York City, told Fox News Digital.
Decotiis, who was not involved in the study, said that liraglutide is not as effective as its newer cousins for weight loss or diabetes, and is not frequently used for these purposes.
"Many pharmacies are not even stocking it due to declining demand, yet it gets into the brain well enough to reduce migraines," she noted.
The trial didn't include a comparison group, and participants and researchers all knew that everyone received liraglutide, the researchers noted.
Mild gastrointestinal side effects (mainly nausea and constipation) occurred in 38% of participants, but did not lead to treatment discontinuation.
Further research may include other groups, such as control groups and people without obesity, to compare the drug's effects.
"The study was very small," Decotiis confirmed to Fox News Digital.
Given its size and brief duration, the findings could be limited until further research is conducted, according to the expert.
The researchers also tested only one drug, liraglutide, "which is not used as frequently in the general population as semaglutide or tirzepatide are," Decotiis added.
For more Health articles, visit www.foxnews.com/health
Next, the team is planning a randomized, double-blind trial that will also measure pressure inside the skull.
"We also want to determine whether other GLP-1 drugs can deliver the same relief, possibly with even fewer gastrointestinal side effects," Braca said in the same press release.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Causes of Depression
Causes of Depression

Health Line

timean hour ago

  • Health Line

Causes of Depression

Key Takeaways The causes of depression are complex and can include genetic predisposition, biochemical imbalances in neurotransmitters, hormonal changes, seasonal patterns, and situational factors like trauma or significant life changes. Diagnosis involves a thorough examination and medical history review by a doctor, potentially including a referral to a psychiatrist. Treatment options include medication, psychotherapy, and lifestyle adjustments, such as exercise and avoiding substance use. What is depression? Depression is a disorder affecting mood and general outlook. A loss of interest in activities or feeling sad and down are symptoms that characterize this condition. Even though most people feel sad or down for brief periods, clinical depression is more than just feeling sad. Depression is a serious medical condition and people usually aren't able to just get over a depressive state. Untreated depression that can cause lasting issues that include: employment problems strain on relationships drug and alcohol abuse suicidal thoughts or attempts Many people who receive effective treatment for depression will go on to live healthy and happy lives. For some, depression may be a lifelong challenge that requires treatment on a long-term basis. Talk to your doctor if you think you are suffering from depression or a major depressive disorder. People of any age and life situation can have depression. What causes depression? Depression isn't a simple condition with a known cause. Some people are more susceptible to depressive episodes while others are not. It's important to discuss symptoms with your doctor. There are several possible causes of depression. Genetic Depression may be an inherited condition. You may have a higher likelihood of experiencing a depressive disorder at some point in your life if you have a family member with depression. The exact genes involved are not known. It's believed that many genes may play a factor in causing depression. Biochemical Some people have noticeable changes in their brains with depression. Even though this potential cause isn't understood, it does suggest depression starts with brain function. Some psychiatrists look at brain chemistry with cases of depression. Neurotransmitters in the brain — specifically serotonin, dopamine, or norepinephrine — affect feelings of happiness and pleasure and may be out of balance in people with depression. Antidepressants work to balance these neurotransmitters, mainly serotonin. How and why these neurotransmitters get out of balance and what role they play in depressive states isn't fully understood. Hormonal Changes in hormone production or functioning could lead to the onset of depressive states. Any changes in hormone states — including menopause, childbirth, thyroid problems, or other disorders — could cause depression. With postpartum depression, mothers develop symptoms of depression after giving birth. It's normal to be emotional because of the changing hormones, but postpartum depression is a serious condition. Seasonal As daylight hours get shorter in the winter, many people develop feelings of lethargy, tiredness, and a loss of interest in everyday activities. This condition was called seasonal affective disorder (SAD). Now it's known as major depressive disorder with seasonal pattern. Your doctor may prescribe medication or a light box to help treat this condition. The condition also usually goes away once the days get longer. Situational Trauma, a big change, or struggle in life can trigger a case of depression. Losing a loved one, being fired, having financial troubles, or undergoing a serious change can have a big impact on people. What are the symptoms of depression? While the symptoms of depression can vary depending on the severity, there are some standard symptoms to watch for. Depression not only affects your thought and feelings, it can also impact how you act, what you say, and your relationships with others. Common symptoms include: sadness tiredness trouble focusing or concentrating unhappiness anger irritability frustration loss of interest in pleasurable or fun activities sleep issues (too much or too little) no energy craving unhealthy foods anxiety isolation restlessness worrying trouble thinking clearly or making decisions poor performance at work or school dropping out of activities guilt suicidal thoughts or tendencies pain, like headaches or muscle aches drug or alcohol abuse Some people also show signs of mania, psychotic episodes, or changes in motor abilities. These can signify other conditions that can cause depression, like bipolar disorder. If you think someone is at immediate risk of self-harm or hurting another person: · Call 911 or your local emergency number. · Stay with the person until help arrives. · Remove any guns, knives, medications, or other things that may cause harm. · Listen, but don't judge, argue, threaten, or yell. If you think someone is considering suicide, get help from a crisis or suicide prevention hotline. Call or text the 988 Suicide and Crisis Lifeline at 988 or use the chat feature at What are the risk factors of depression? Many factors can increase your risk of developing depression at some point in your life. Risk factors include: being a woman (more women are diagnosed with depression than men) having low self-esteem having blood relatives with depression being gay, lesbian, bisexual, or transgender having other mental health disorders, like anxiety or bipolar disorder abusing drugs or alcohol having a serious or chronic illness taking certain medications, like sleeping pills living in a region of the world that has long winter nights and limited sunlight How is depression diagnosed? To diagnose depression your doctor will do a full examination and get your medical history. They may refer you to a psychiatrist for a more in-depth evaluation. Since depression can't be tested for using blood tests, your doctor will ask you questions about your thoughts and feelings. Your doctor will be able to diagnose you based on your symptoms and answers.

What Screening Tools Are Used for Depression?
What Screening Tools Are Used for Depression?

Health Line

timean hour ago

  • Health Line

What Screening Tools Are Used for Depression?

Key Takeaways Depression screening tools are self-report surveys used to help diagnose depression by evaluating the presence and severity of depressive symptoms. These tools are not 100% reliable but can help healthcare professionals determine the next best steps for treatment. Common assessment tools include the Patient Health Questionnaire (PHQ), Beck Depression Inventory (BDI), Children's Depression Inventory (CDI), Geriatric Depression Scale (GDS), and Edinburgh Postnatal Depression Scale (EPDS). Each is tailored for different age groups or circumstances. Following a test, a healthcare professional can recommend a treatment plan, which may include medications psychotherapy and self-care strategies like yoga, meditation, and exercise. Depression is a common experience affecting up to 6% of the world's population. It typically includes a set of symptoms in varying intensity that affect both mood and behavior. In the worst case, depression can also interfere with your ability to work or maintain relationships. Healthcare professionals are trained to diagnose conditions with the help of tools and technology. Depression screening tests are one type of tool that professionals can use to screen you for the presence of depressive symptoms. If you've been experiencing symptoms of depression and are thinking about seeing a mental health professional, you may be given a depression screening test. The test is simple and easy, and will be followed by a treatment plan. What are depression screening tools? Depression screening tools refer to a number of different self-report surveys used to determine if you've been experiencing symptoms of major depressive disorder. They're mostly pen-and-paper assessments, but you can also fill them out electronically. How does a depression test work? Depression tests list various questions related to depression symptoms, and some will also ask you to rate the severity of those symptoms. Symptom severity corresponds to either the frequency or degree that you experience them. A health professional will give you the test to fill out during your visit. There are various types of depression tests. Some tests are used for specific age groups, whereas others are used for specific circumstances. None are 100% reliable, but several commonly used tests can help diagnose depression with good overall accuracy. The tests usually take a few minutes to complete and are straightforward, requiring no past medical history or other information. After you complete the test, the health professional will then evaluate your responses and determine the next best step. Most common depression assessment instruments Patient Health Questionnaire (PHQ) The Patient Health Questionnaire (PHQ) is often a first-choice tool used by primary care professionals for most people. This is because it can help diagnose depression between 78% and 94% of the time. It can either be a two-question survey (PHQ-2) or a nine-question survey (PHQ-9). The PHQ-2 is typically given first to assess for the overall presence of depressed mood. If necessary, it will be followed by the PHQ-9, which is more detailed and can help detect the overall severity of depression. The PHQ asks how many days per week you experience specific symptoms. Beck Depression Inventory (BDI) The Beck Depression Inventory (BDI) consists of 21 depression-related questions. It asks that you rate the presence of key symptoms on a scale between 0 and 3. Higher scores indicate a more severe form of depression. The BDI is generally considered a reliable and accurate test. Children's Depression Inventory (CDI) The Children's Depression Inventory (CDI) is given to children and adolescents between the ages of 7 and 17. It's written in simple language at a first-grade reading level. It has between 10 and 27 questions. A 2016 study showed that it's between 44% and 76% effective at helping diagnose depression in children. Geriatric Depression Scale (GDS) The Geriatric Depression Scale (GDS) is used for older adults ages 60 and over. The questions are in a yes-or-no format rather than a severity rating. It can have from 4 to 30 questions, and helps diagnose depression with 75% to 86% accuracy. Edinburgh Postnatal Depression Scale (EPDS) If you've recently given birth and have been feeling blue, you may be given the 10-question Edinburgh Postnatal Depression Scale (EPDS). The Edinburgh scale asks you to rate the presence of certain symptoms experienced over the past week. A 2019 study found that the EPDS was approximately 94% effective. Who can administer a depression test? Any healthcare professional involved in some aspect of mental or behavioral health can administer the test. A specialist isn't required. This is because these tests are simple to administer and interpret. This means you can speak with a primary care professional, a licensed mental health counselor, a social worker, or a psychologist. After taking the test, your healthcare professional can help you determine your best treatment plan. Bottom line Depression screening tools are a valuable and simple asset for healthcare professionals. They're mostly accurate at determining both the presence and degree of depressive symptoms, and they're generally easy to fill out. If you're feeling symptoms of depression, visiting a healthcare professional is the first step in evaluating you for major depressive disorder. Based on your results, a mental health professional can work with you to determine a treatment plan.

Historic Medicaid cuts to come as Trump signs domestic policy bill
Historic Medicaid cuts to come as Trump signs domestic policy bill

Yahoo

time2 hours ago

  • Yahoo

Historic Medicaid cuts to come as Trump signs domestic policy bill

This story was originally published on Healthcare Dive. To receive daily news and insights, subscribe to our free daily Healthcare Dive newsletter. President Donald Trump on Friday signed Republicans' major tax and domestic policy bill into law, setting into motion massive cuts to Medicaid that could remove millions of people from the safety-net insurance coverage. The legislation was sent to Trump's desk on Thursday, after months of rancorous debate in Congress. The Senate narrowly passed its version of the bill earlier this week, calling in Vice President JD Vance to cast the tiebreaking vote. House Republicans then scrambled to get their caucus in line, as moderates raised concerns about the Senate's steeper cuts to Medicaid and conservatives lambasted the legislation's growing contribution to the national debt. But the lower chamber ultimately voted to pass the megabill 218 to 214, nearly entirely along party lines. Only two Republicans, Reps. Thomas Massie of Kentucky and Brian Fitzpatrick of Pennsylvania, declined to support the legislation. GOP lawmakers cheered its passage Thursday. Rep. Brett Guthrie, R-Ky., chairman of the House Committee on Energy and Commerce, said the law 'strengthens Medicaid for those who need it most.' Here are some of the healthcare provisions in the law: Medicaid work requirements. Some beneficiaries in the safety-net insurance program — including childless adults and those with children older than 14 — would need to work, volunteer or go to school at least 80 hours a month to stay enrolled. Medicaid eligibility. States would be required to check enrollees' eligibility for the coverage every six months instead of yearly. The law also prevents the HHS from enforcing a regulation that aimed to streamline eligibility and enrollment for Medicaid and the Children's Health Insurance Program. Cost-sharing in Medicaid. Higher-income beneficiaries would have to pay cost-sharing up to $35 per service for some care. Provider taxes. The law freezes provider taxes — arrangements states use to finance their share of Medicaid funding — in states that haven't expanded Medicaid, and gradually lowers allowed rates in expansion states. State-directed payments. The arrangements that allow states to make supplemental payments for services covered in Medicaid managed care contracts face new restrictions. The law directs the HHS to revise that payment limit from the average commercial rate to Medicare rates in expansion states, and 10% above the Medicare rate in non-expansion states. Affordable Care Act subsidy verification. The law requires pre-enrollment verification of eligibility for premium tax credits that subsidize the cost of health plans on the ACA exchanges. Limit immigrant eligibility for Medicare, Medicaid and ACA premium tax credits. Only green card holders and certain classes of immigrants would be eligible for these programs. Cut Medicaid funding to Planned Parenthood. The law blocks Medicaid funds for services offered by abortion providers like Planned Parenthood for one year. Rural healthcare support. The policy includes a $50 billion fund to help states support providers and hospitals in rural communities. Nursing home staffing. The HHS is prohibited from enforcing a Biden-era regulation that would have required long-term care facilities to increase staffing and have a registered nurse on-site. The Medicaid provisions of the law have been some of the most contentious. The policies reduce federal spending on the safety-net coverage by $1 trillion, according to a Tuesday estimate by health policy researcher KFF. Nearly 12 million additional people would become uninsured by 2034 under the law, according to an analysis published Saturday by the Congressional Budget Office. As such, the policies have been lambasted by the healthcare sector. Hospitals worry the growing number of uninsured patients would cause uncompensated care to soar, weighing on their bottom lines. Rural hospitals and providers that serve large numbers of Medicaid patients would be particularly hard hit, forcing them to cut services to close their doors altogether, experts say. Dr. Bobby Mukkamala, president of the American Medical Association, said in a statement Thursday the impact from the law 'will reverberate for years,' leaving patients sicker with less access to care. Chip Kahn, president and CEO of the Federation of American Hospitals, urged Congress to take action to mitigate damage from the law's healthcare provisions by extending enhanced financial assistance for people who buy coverage on the ACA marketplaces, which is set to lapse at the end of the year. 'Time is of the essence,' he said in a Thursday statement. 'Without action extending these credits, we will see the gains to health care access and affordability our country has made over the years further evaporate, and too many will not be able to pick up the slack.' Recommended Reading Senate passes Trump's spending bill with massive Medicaid cuts

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store